NCT03622788 2025-12-17Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting16 enrolled
NCT00856388 2019-11-13Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersRoswell Park Cancer InstitutePhase NA Completed62 enrolled 14 charts
NCT00720629 2014-07-18Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated8 enrolled 11 charts